Your browser doesn't support javascript.
loading
Predictive lifestyle markers for efficacy of cancer immune checkpoint inhibitors: a commentary.
Sillah, Arthur; Tykodi, Scott S; Hall, Evan T; Thompson, John A; Watson, Nathaniel F; Lee, Sylvia M; Bhatia, Shailender; Veatch, Joshua; Warner, Jeannie; Peters, Ulrike; Malen, Rachel C; Silverman, Allison; Phipps, Amanda I.
Afiliação
  • Sillah A; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA 98195, USA.
  • Tykodi SS; Epidemiology Program, Fred Hutchinson Research Cancer Research Center, Seattle, WA 98133, USA.
  • Hall ET; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98133, USA.
  • Thompson JA; Seattle Cancer Care Alliance, Seattle, WA 98133, USA.
  • Watson NF; University of Washington School of Medicine, Division of Medical Oncology, Seattle, WA 98195, USA.
  • Lee SM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98133, USA.
  • Bhatia S; Seattle Cancer Care Alliance, Seattle, WA 98133, USA.
  • Veatch J; University of Washington School of Medicine, Division of Medical Oncology, Seattle, WA 98195, USA.
  • Warner J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98133, USA.
  • Peters U; Seattle Cancer Care Alliance, Seattle, WA 98133, USA.
  • Malen RC; University of Washington School of Medicine, Division of Medical Oncology, Seattle, WA 98195, USA.
  • Silverman A; University of Washington School of Medicine, Department of Neurology & University of Washington Sleep Medicine Center, Seattle, WA 98195, USA.
  • Phipps AI; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98133, USA.
Future Oncol ; 17(4): 363-369, 2021 Feb.
Article em En | MEDLINE | ID: mdl-33397134
Lifestyle factors could plausibly modulate the host immune system, the tumor microenvironment and, hence, immune checkpoint inhibitor (ICI) response. As such, these factors should be considered in ICI studies.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article